Add to Favourites
To login click here
This report provides an in-depth analysis of the global AI-based Clinical Trial Solutions for Patient Matching Market. It is estimated that the market size will reach USD 1,969 million by 2030, with North America dominating the market in terms of revenue in 2021. Factors such as increased government and corporate investment in AI-based technologies, the presence of biopharmaceutical companies, and the rising prevalence of diseases in the region are expected to contribute to the market growth. Europe is the second-largest market for AI-based Clinical Trials Solution Providers, followed by the ASEAN region. Traditional R&D processes are being replaced by AI-based solutions, which is expected to drive the market growth.